Fundraising FoxChirality Biosciences
Farmingdale, US · Founded 2023 · Delaware corporation · 1 known investors
Find your way into Chirality Biosciences
Sign up to see every warm intro you have to Chirality Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chirality Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Chirality develops a proprietary chiral separation technology to produce higher-purity, safer pharmaceutical compounds with less waste than conventional methods like HPLC. It serves scientists and pharmaceutical manufacturers seeking faster, cleaner paths to drug production.
Founders & leadership
Board
RK
Robert KaytonBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.1M disclosed across 1 round · 2025
▶$3.1MraisedOct 2025 · 9 investors · OtherRule 506(b)
▶$3.1MraisedOct 2025 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Arielle GabalskiExecutive Officer, Director
- Robert KaytonDirector
- Joanna Jennings EagleExecutive Officer
- Offering amount
- $4.1M
- Amount sold
- $3.1M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
UCeed FundsThe University of Calgary is a public research university in Calgary, Canada, offering undergraduate and graduate education across disciplines and supporting research and entrepreneurship. It serves students, researchers, and student-athletes.
LumenLumen Learning provides courseware and teaching tools built on open educational resources (OER) for higher education, aimed at faculty and students. Its products support course delivery, faculty professional development, and student-centered learning in colleges and universities.
Companies working in the same space as Chirality Biosciences.
Frequently asked questions
- What does Chirality Biosciences do?
- Chirality develops a proprietary chiral separation technology to produce higher-purity, safer pharmaceutical compounds with less waste than conventional methods like HPLC. It serves scientists and pharmaceutical manufacturers seeking faster, cleaner paths to drug production.
- Who are Chirality Biosciences's investors?
- Chirality Biosciences's investors include Collaborative Fund.
- How much funding has Chirality Biosciences raised?
- Chirality Biosciences has disclosed $3.1M raised across 1 round.
- Where is Chirality Biosciences headquartered?
- Chirality Biosciences is headquartered in Farmingdale, US.